L

Lantern Pharma
D

LTRN

3.50000
USD
0.08
(2.34%)
Market Open
Volume
125
EPS
0
Div Yield
0
P/E
-2
Market Cap
37,676,538
Related Instruments
    A
    ATOM
    -0.39200
    (-11.16%)
    3.12000 USD
    K
    KSM
    -0.04000
    (-0.40%)
    9.96000 USD
    S
    SOL
    -0.07500
    (-4.50%)
    1.59000 USD
    More
News

Title: Lantern Pharma

Sector: Healthcare
Industry: Biotechnology
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.